封面故事：欧元。[j] .免疫学杂志，2010

IF 3.7 3区医学 Q2 IMMUNOLOGY

European Journal of Immunology Pub Date : 2025-10-03 DOI:10.1002/eji.70074

{"title":"封面故事：欧元。[j] .免疫学杂志，2010","authors":"","doi":"10.1002/eji.70074","DOIUrl":null,"url":null,"abstract":"<p>The cover image is based on the article Activation of CD8<sup>+</sup> T cells in the human ex vivo lung tumor microenvironment using anti-CD3/CD28 and Nivolumab by Tonia Bargmann et al., https://doi.org/10.1002/eji.70060\n \n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":165,"journal":{"name":"European Journal of Immunology","volume":"55 10","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.70074","citationCount":"0","resultStr":"{\"title\":\"Cover Story: Eur. J. Immunol. 10'25\",\"authors\":\"\",\"doi\":\"10.1002/eji.70074\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The cover image is based on the article Activation of CD8<sup>+</sup> T cells in the human ex vivo lung tumor microenvironment using anti-CD3/CD28 and Nivolumab by Tonia Bargmann et al., https://doi.org/10.1002/eji.70060\\n \\n <figure>\\n <div><picture>\\n <source></source></picture><p></p>\\n </div>\\n </figure></p>\",\"PeriodicalId\":165,\"journal\":{\"name\":\"European Journal of Immunology\",\"volume\":\"55 10\",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.70074\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/eji.70074\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/eji.70074","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

封面图片基于Tonia Bargmann等人的文章《利用抗cd3 /CD28和Nivolumab激活人离体肺肿瘤微环境中的CD8+ T细胞》，https://doi.org/10.1002/eji.70060

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Cover Story: Eur. J. Immunol. 10'25

查看原文本刊更多论文

Cover Story: Eur. J. Immunol. 10'25

The cover image is based on the article Activation of CD8⁺ T cells in the human ex vivo lung tumor microenvironment using anti-CD3/CD28 and Nivolumab by Tonia Bargmann et al., https://doi.org/10.1002/eji.70060

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European Journal of Immunology 医学-免疫学

CiteScore

8.30

自引率

3.70%

发文量

224

审稿时长

2 months

期刊介绍： The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.